
Tangle Can abortion pills be prescribed online?
May 6, 2026
A legal fight over whether mifepristone can be prescribed and mailed through telehealth, with the Supreme Court pausing a lower court’s in-person requirement. Background on FDA approvals, REMS changes, and conflicting safety studies. Heated political angles from left and right about risks and electoral fallout. Personal ethics, coercion concerns, and how courts might decide.
AI Snips
Chapters
Transcript
Episode notes
Supreme Court Paused In-Person Requirement For Mifepristone
- The Supreme Court temporarily paused a Fifth Circuit order that would have required in-person prescribing of mifepristone, restoring telehealth and mail access until May 11, 2026.
- Justice Samuel Alito issued the brief stay giving challengers until May 7 to respond while the Court considers longer-term action.
Mifepristone Has Long Track Record And Evolving FDA Rules
- Mifepristone has broad non-abortion uses and long usage data: over 6 million U.S. patients used it from 2000–2022 and 63% of 2023 abortions were medication abortions.
- The FDA progressively relaxed rules: 2016 approval to 10 weeks, 2021 removal of in-person requirement, and 2023 finalizing mail access.
Left Frames Ruling As Incremental Threat To Abortion Access
- Left-leaning analysts warn the Fifth Circuit ruling could destabilize GOP politics and erode access incrementally rather than via a single nationwide ban.
- They argue the movement aims to slowly restrict access through agency challenges, legislation, and state actions.
